Akums launches dual-action heartburn relief chewable tablets

The product is designed to provide rapid and long-lasting relief for individuals suffering from GERD and related symptoms

Akums Drugs and Pharmaceuticals has introduced dual-action heartburn relief chewable tablet, combining Famotidine, Calcium Carbonate, and Magnesium Hydroxide. The product is designed to provide rapid and long-lasting relief for individuals suffering from gastroesophageal reflux disease (GERD) and related symptoms.

This groundbreaking formulation pairs an antacid, which offers immediate neutralisation of stomach acid, with Famotidine, a Histamine H2-receptor antagonist that reduces acid production for extended relief. Akums is again setting new standards in pharmaceutical excellence, ensuring patients can access advanced, reliable healthcare solutions.

Sanjeev Jain, MD, Akums Drugs and Pharmaceuticals, expressed excitement about the launch, "Heartburn is a widespread issue that affects millions. At Akums, we are dedicated to developing effective solutions for health concerns. Our dual-action chewable tablet is an innovative solution, providing fast, safe, and long-lasting heartburn relief."

Sandeep Jain, MD, Akums, emphasised the importance of this product for the Indian market: "With the rising prevalence of GERD and similar conditions, there is a clear demand for treatments that go beyond temporary relief. Our dual-action chewable tablets offer a comprehensive solution, providing rapid symptom relief and preventing recurrence. We’re proud of our R&D team for this innovative formulation."